SCHEMBL3377753

SCHEMBL3377753

NC12CC3CC(C1)CC(NC(=O)c1cccc(Cl)c1)(C3)C2

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 4/20 0.54
P2RX7 Q99572 1/20 0.53
L3MBTL1 Q9Y468 1/20 0.52
KMT2A Q03164 3/20 0.50
CNR2 P34972 2/20 0.50
MEN1 O00255 2/20 0.50
ATM Q13315 1/20 0.49
HSD11B1 P28845 1/20 0.47
KDM4E B2RXH2 1/20 0.47
NPC1 O15118 1/20 0.47
ALDH1A1 P00352 1/20 0.47
LMNA P02545 1/20 0.47
MAPT P10636 1/20 0.47
RAB9A P51151 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
TSHR P16473 1/20 0.47
PBK Q96KB5 1/20 0.47
IDO1 P14902 1/20 0.46
DPP8 Q6V1X1 1/20 0.46
DPP9 Q86TI2 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1578574 0.91 FAAH (0.60) FAAHP2RX7L3MBTL1KMT2ACNR2
SCHEMBL3376422 0.86 FAAH (0.74) FAAHL3MBTL1KMT2ACNR2MEN1
SCHEMBL3377748 0.86 FAAH (0.52) FAAHP2RX7L3MBTL1KMT2ACNR2
SCHEMBL1578168 0.85 GRM5 (0.55) FAAHL3MBTL1KMT2ACNR2MEN1
SCHEMBL2638678 0.85 FAAH (0.51) FAAHL3MBTL1KMT2ACNR2MEN1
SCHEMBL2639172 0.84 FAAH (0.70) FAAHL3MBTL1CNR2ATMKDM4E
SCHEMBL16244318 0.83 P2RX7 (0.60) FAAHP2RX7L3MBTL1KMT2ACNR2
Hydrochloric Acid SCHEMBL30685078 0.83 FAAH (0.54) FAAHL3MBTL1KMT2ACNR2MEN1
SCHEMBL16244546 0.83 FAAH (0.52) FAAHP2RX7L3MBTL1KMT2ACNR2
SCHEMBL2638039 0.83 STS (0.51) FAAHL3MBTL1KMT2ACNR2ATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2310356-B1 ADAMANTYL DIAMIDE DERIVATIVES AND USES OF SAME LUNDBECK & CO AS H (DK) 2013-08-14 EP claimed
US-20100022546-A1 ADAMANTYL DIAMIDE DERIVATIVES AND USES OF SAME H. LUNDBECK A/S (DK) 2010-01-28 US claimed
US-8716284-B2 Adamantyl diamide derivatives and uses of same H. LUNDBECK A/S (DK) 2014-05-06 US disclosed
EP-2310356-B1 ADAMANTYL DIAMIDE DERIVATIVES AND USES OF SAME LUNDBECK & CO AS H (DK) 2013-08-14 EP disclosed
US-8389519-B2 Adamantyl diamide derivatives and uses of same H. LUNDBECK A/S (DK) 2013-03-05 US disclosed
US-20120270873-A1 ADAMANTYL DIAMIDE DERIVATIVES AND USES OF SAME H. LUNDBECK A/S (DK) 2012-10-25 US disclosed
US-8198275-B2 Adamantyl diamide derivatives and uses of same H. LUNDBECK A/S (DK) 2012-06-12 US disclosed
US-20100022546-A1 ADAMANTYL DIAMIDE DERIVATIVES AND USES OF SAME H. LUNDBECK A/S (DK) 2010-01-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120270873-A1 ADAMANTYL DIAMIDE DERIVATIVES AND USES OF SAME QDPR, PDE3B, ADM2 FAAH 2836/4885P2RX7 1400/4885L3MBTL1 4856/4885
US-20100022546-A1 ADAMANTYL DIAMIDE DERIVATIVES AND USES OF SAME QDPR, ADM2, PDE3B FAAH 2906/4885P2RX7 1517/4885L3MBTL1 4842/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.